Dilep Kumar Sigalapalli - Vignan Pharmacy College, Jawaharlal Nehru Technological University

基本信息

Career Trajectory

Bio

In silico Medicinal Chemistry, Drug Design and Synthesis

Research Interests

Papers共 49 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Computational Elucidation of Human Β-Defensin-2 As a Dual Inhibitor of MMP-9 and PKC-βII for Diabetic Wound Management

Vidyasrilekha Sanapalli,Dilep Kumar Sigalapalli,Afzal B. Shaik,Richie R. Bhandare,Bharat Kumar Reddy Sanapalli

ACS OMEGA（2025）

Cited0Views0WOSBibtex

Unveiling the Unexplored Multifactorial Potential of 5-Aminosalicylic Acid in Diabetic Wound Therapy

Bharat Kumar Reddy Sanapalli,Ashwini Deshpande, Vidyasrilekha Sanapalli,Dilep Kumar Sigalapalli

Diseases（2024）

Cited0Views0WOSBibtex

Bacterial Histidine Kinase and the Development of Its Inhibitors in the 21st Century

Ragib Ahsan,Sumaiya Kifayat, Krishan Kumar Pooniya, Sunita Kularia, Bhavani Sailu Adimalla,Bharat Kumar Reddy Sanapalli, Vidyasrilekha Sanapalli,Dilep Kumar Sigalapalli

ANTIBIOTICS-BASEL（2024）

Cited0Views0WOSBibtex

Development of Novel Indole-3-sulfonamide-heteroaryl Hybrids As Carbonic Anhydrase Inhibitors: Design, Synthesis and In-Vitro Screening

Krishna K. Chinchilli,Priti Singh,Baijayantimala Swain,Nerella S. Goud,Dilep K. Sigalapalli,Abhishek Choli,Andrea Angeli,Srinivas Nanduri,Venkata M. Yaddanapudi,Claudiu T. Supuran,Mohammed Arifuddin

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRYno. 11 (2023): 1225-1233

Cited3Views0WOSBibtex

6-Shogaol Exhibits Anti-viral and Anti-inflammatory Activity in COVID-19-Associated Inflammation by Regulating NLRP3 Inflammasomes

Jyoti Kode,Jitendra Maharana,Asif Amin Dar,Shayanti Mukherjee,Nikhil Gadewal,Dilep Kumar Sigalapalli,Satyanshu Kumar,Debashis Panda,Soumyajit Ghosh,Supriya Suman Keshry,Prabhudutta Mamidi,Soma Chattopadhyay,Trupti Pradhan, Vaishali Kailaje, Sunil Inamdar,Vidula Gujjarwar

ACS OMEGA（2023）

Cited9Views0WOSBibtex

Filamentous Temperature Sensitive Mutant Z: a Putative Target to Combat Antibacterial Resistance

Sumaiya Kifayat,Vidyasrilekha Yele,Akram Ashames,Dilep Kumar Sigalapalli,Richie R Bhandare,Afzal B Shaik,Venkatarathnam Nasipireddy,Bharat Kumar Reddy Sanapalli

RSC advances（2023）

Cited4Views0WOSBibtex

6 an Overview of in Silico Methods Used in the Design of VEGFR-2 Inhibitors As Anticancer Agents

Richie R. Bhandare,Bulti Bakchi,Dilep Kumar Sigalapalli,Afzal B Shaik

In Silico Chemistry and Biologypp.115-132, (2022)

Cited0Views0Bibtex

Forging of Nicotine for the Effective Management of Diabetic Wounds: A Hybrid of Scaffold Hopping and Molecular Dynamics Simulation Approaches

Bharat Kumar Reddy Sanapalli,Vidyasrilekha Yele,Dilep Kumar Sigalapalli,Nikhil Gadewal,Afzal B. Shaik,Richie R. Bhandare,Sivakumar Annadurai,Veera Venkata Satyanarayana Reddy Karri

Arabian Journal of Chemistry（2022）

Cited2Views0Bibtex

An Overview on Applications of SwissADME Web Tool in the Design and Development of Anticancer, Antitubercular and Antimicrobial Agents: A Medicinal Chemist's Perspective

Bulti Bakchi, Ambati Dileep Krishna, Ekambarapu Sreecharan, Veeramallu Bala Jaya Ganesh, Muraboina Niharika, Suryadevara Maharshi,Srinivasa Babu Puttagunta,Dilep Kumar Sigalapalli,Richie R. Bhandare,Afzal B. Shaik

Journal of Molecular Structure（2022）

Cited109Views0Bibtex

109

Semisynthetic Transformations on (+)-Boldine Reveal a 5-HT2A/2CR Antagonist

Hari K. Namballa,Sudharshan Madapa,Dilep K. Sigalapalli,Wayne W. Harding

JOURNAL OF NATURAL PRODUCTS（2022）

Cited3Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn